Skip to main content
Clinical Trials/NCT04454203
NCT04454203
Recruiting
Phase 4

Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension

Duke University1 site in 1 country40 target enrollmentStarted: February 5, 2021Last updated:

Overview

Phase
Phase 4
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Change in tourniquet hypertension as measured by systolic blood pressure

Overview

Brief Summary

The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time.

Detailed Description

This is a research study to find out if injection of numbing medication by the large artery going down your leg will improve high blood pressure caused by the tourniquet.

Depending on whether you enroll in this study, you may receive an injection of local anesthetic (numbing medication) or saline (salt water) by your femoral artery (the large artery going down your leg). This is to see how this injection impacts your blood pressure during surgery as the surgeons use a tourniquet (device that squeezes your leg) to help decrease the bleeding during surgery. Oftentimes the tourniquet causes your blood pressure to go up, but the numbing medication may help return your blood pressure close to its normal level. The rest of your anesthesia care, including other nerve blocks and general anesthetic, will be the same as it would be without participating in the study. You will be enrolled in this study for 24 hours.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients that will be included in the study are English speaking 18-75 year old ASA 1-3 patients undergoing total ankle arthroplasty.

Exclusion Criteria

  • Diagnosis of chronic pain
  • Daily chronic opioid use (over 3 months of continuous opioid use).
  • Inability to communicate pain scores or need for analgesia.
  • Infection at the site of block placement
  • Age under 18 years old or greater than 75 years old
  • Pregnant women (as determined by standard of care day-of surgery urine bHCG)
  • Intolerance/allergy to local anesthetics
  • Weight \<50 kg
  • Suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past 2 years.
  • Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the opinion of the investigator, may interfere with study assessments or compliance.

Arms & Interventions

Mepivacaine Block Group

Experimental

Infiltration of local anesthetic (mepivacaine) above and beside the femoral artery through a perineural catheter.

Intervention: Mepivacaine (Drug)

Mepivacaine Block Group

Experimental

Infiltration of local anesthetic (mepivacaine) above and beside the femoral artery through a perineural catheter.

Intervention: Perifemoral Injection of Local Anesthetic (Procedure)

Saline Sham Group

Placebo Comparator

Infiltration of salt water (saline) above and beside the femoral artery through a perineural catheter.

Intervention: Saline (Drug)

Saline Sham Group

Placebo Comparator

Infiltration of salt water (saline) above and beside the femoral artery through a perineural catheter.

Intervention: Perifemoral Injection of Local Anesthetic (Procedure)

Outcomes

Primary Outcomes

Change in tourniquet hypertension as measured by systolic blood pressure

Time Frame: From time of injection to 30 minutes after injection

Infiltrating study drug to reverse intraoperative tourniquet hypertension

Secondary Outcomes

  • Opioid consumption(Perioperative start until 2 hours after admission to PACU)
  • Pain Scores (NRS11)(Perioperative start until 2 hours after admission to PACU)
  • Quadriceps motor function(1 hour after extubation)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials